View in EDS

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.

Saved in:
Bibliographic Details
Title: Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.
Authors: Hamid O; The Angeles Clinic and Research Institute, Los Angeles, California. ohamid@theangelesclinic.org., Molinero L; Genentech, Inc., South San Francisco, California., Bolen CR; Genentech, Inc., South San Francisco, California., Sosman JA; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Muñoz-Couselo E; Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, Barcelona, Spain., Kluger HM; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut., McDermott DF; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sarkar I; Genentech, Inc., South San Francisco, California., Ballinger M; Genentech, Inc., South San Francisco, California., Fassò M; Genentech, Inc., South San Francisco, California., O'Hear C; Genentech, Inc., South San Francisco, California., Chen DS; Genentech, Inc., South San Francisco, California., Hegde PS; Genentech, Inc., South San Francisco, California., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Oct 15; Vol. 25 (20), pp. 6061-6072. Date of Electronic Publication: 2019 Jul 29.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31358540
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamid+O%22">Hamid O</searchLink>; The Angeles Clinic and Research Institute, Los Angeles, California. ohamid@theangelesclinic.org.<br /><searchLink fieldCode="AU" term="%22Molinero+L%22">Molinero L</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Bolen+CR%22">Bolen CR</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Sosman+JA%22">Sosman JA</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Muñoz-Couselo+E%22">Muñoz-Couselo E</searchLink>; Vall d'Hebrón University Hospital and Vall d'Hebrón Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Kluger+HM%22">Kluger HM</searchLink>; Yale University School of Medicine and Yale Cancer Center, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22McDermott+DF%22">McDermott DF</searchLink>; Beth Israel Deaconess Medical Center, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Powderly+JD%22">Powderly JD</searchLink>; Carolina BioOncology Institute, Huntersville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Sarkar+I%22">Sarkar I</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Ballinger+M%22">Ballinger M</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Fassò+M%22">Fassò M</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22O'Hear+C%22">O'Hear C</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Chen+DS%22">Chen DS</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Hegde+PS%22">Hegde PS</searchLink>; Genentech, Inc., South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Hodi+FS%22">Hodi FS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2019 Oct 15; Vol. 25 (20), pp. 6061-6072. <i>Date of Electronic Publication: </i>2019 Jul 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31358540
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-18-3488
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6061
    Titles:
      – TitleFull: Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamid O
      – PersonEntity:
          Name:
            NameFull: Molinero L
      – PersonEntity:
          Name:
            NameFull: Bolen CR
      – PersonEntity:
          Name:
            NameFull: Sosman JA
      – PersonEntity:
          Name:
            NameFull: Muñoz-Couselo E
      – PersonEntity:
          Name:
            NameFull: Kluger HM
      – PersonEntity:
          Name:
            NameFull: McDermott DF
      – PersonEntity:
          Name:
            NameFull: Powderly JD
      – PersonEntity:
          Name:
            NameFull: Sarkar I
      – PersonEntity:
          Name:
            NameFull: Ballinger M
      – PersonEntity:
          Name:
            NameFull: Fassò M
      – PersonEntity:
          Name:
            NameFull: O'Hear C
      – PersonEntity:
          Name:
            NameFull: Chen DS
      – PersonEntity:
          Name:
            NameFull: Hegde PS
      – PersonEntity:
          Name:
            NameFull: Hodi FS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 2019 Oct 15
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 20
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1